Some relief from the epidemic.
Cadman
J A
JA
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality*; D019380:Anti-HIV Agents / Q000627:therapeutic use; D002487:Centers for Disease Control and Prevention, U.S.; D016527:Drug Costs; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006297:Health Services Accessibility; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D009519:New York City / Q000453:epidemiology; D011159:Population Surveillance; D015995:Prevalence; D014481:United States / Q000453:epidemiology
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D019259:Lamivudine